Fig. 6From: Effect of janus kinase inhibitors and methotrexate combination on malignancy in patients with rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trialsRRs of safety adverse events (SAE) in patients with RA treated with JAKi and MTX compared to MTX alone in RCTs using the M–H random-effect methodBack to article page